p21 maintains senescent cell viability under persistent DNA damage response by restraining JNK and caspase signaling
Open accessThe DOI matches its Crossref record; 57 of the 58 references it cites were found in a registry or an index, and 1 are not checked yet; 7 of the 38 sources its claims cite were checked for support.
Abstract
Cellular senescence is a permanent state of cell cycle arrest that protects the organism from tumorigenesis and regulates tissue integrity upon damage and during tissue remodeling. However, accumulation of senescent cells in tissues during aging contributes to age‐related pathologies. A deeper understanding of the mechanisms regulating the viability of senescent cells is therefore required. Here, we show that the CDK inhibitor p21 (CDKN1A) maintains the viability of DNA damage‐induced senescent cells. Upon p21 knockdown, senescent cells acquired multiple DNA lesions that activated ataxia telangiectasia mutated (ATM) and nuclear factor (NF)‐κB kinase, leading to decreased cell survival. NF‐κB activation induced TNF‐α secretion and JNK activation to mediate death of senescent cells in a caspase‐ and JNK‐dependent manner. Notably, p21 knockout in mice eliminated liver senescent stellate cells and alleviated liver fibrosis and collagen production. These findings define a novel pathway that regulates senescent cell viability and fibrosis.
Verified 2026-10-05 · 1 reference not checked yet
Overview
CoChat Summary
TL;DR
p21 (CDKN1A) is required to maintain the viability of DNA damage-induced senescent cells, and its loss triggers ATM/NF-κB/TNF-α/JNK signaling and caspase-dependent death. In mice, p21 knockout reduces senescent cells in fibrotic liver and alleviates liver fibrosis.
Key findings
- p21 knockdown selectively killed DNA damage-induced senescent (DIS) cells: 30% death in IMR-90 DIS cells, 26% reduction in DIS MEFs, 54% reduction in DIS BJ cells, and 60% lower viability in p21−/− MEFs versus WT; H1299 cells showed 75% reduction after p21 shRNA and etoposide.
- p21 knockdown in DIS cells intensified the DNA damage response (increased p-ATM, p-CHK2, γH2AX, p53), resumed DNA synthesis (BrdU incorporation), caused fragmented chromosomes/micronucleation, and increased sub-G1; microarrays showed 1,595 unique genes changed versus 82 in growing cells, with TNF-α mRNA increased 30-fold.
- Death after p21 knockdown was caspase- and JNK-dependent: pan-caspase inhibitor QVD only partially rescued viability (17% increase), while combined QVD plus JNK inhibitor or JNK knockdown completely rescued; p65 knockdown blocked TNF-α production but did not rescue death.
- In CCl4-treated mice, p21−/− livers had significantly fewer senescent cells, detectable apoptotic cells, reduced Sirius Red fibrosis, and lower TGF-β, COL1A1, and α-SMA expression; p21 knockdown also reduced COL1A1 mRNA by 48% at 24 h before cell death.
Methods
- In vitro senescence models used human IMR-90 and BJ fibroblasts, mouse embryonic fibroblasts, and H1299 cells; DIS was induced with etoposide (20 μM for MEFs/H1299, 50 μM for BJ/IMR-90) for 48 h, and OIS with H-RasV12. p21, p53, pRb, p65, or JNK1 were knocked down by siRNA/shRNA; viability was measured with PrestoBlue, with QVD, z-VAD, or SP600125 treatments where indicated.
- Molecular analyses included Affymetrix PrimeView microarrays (3 replicates) with WikiPathways/IPA enrichment, RT–PCR, immunoblotting, immunofluorescence, comet assay, BrdU incorporation, cell cycle flow cytometry, and ImageStreamX γH2AX foci quantification.
- In vivo, WT and p21−/− 8-week-old female mice received CCl4 for 6 weeks (n = 10 per group); livers were analyzed by SA-β-gal, cleaved caspase-3, Sirius Red, and RT–PCR. Statistical significance used Student’s t-test with P < 0.05.
Limitations
- The paper states that direct regulation of JNK phosphorylation and caspases by p21 cannot be excluded, and that further research is required to define the mode of cell death after p21 knockdown (e.g., necrotic or autophagic versus apoptotic).
- The paper states that mice were assigned to experimental groups by genotype without randomization or blinding.
- Evident from the text: the in vitro work relies mainly on fibroblast lines and one cancer line, and the in vivo work is limited to CCl4-induced liver fibrosis in female mice, so generalizability to other senescent cell types, tissues, and aging models is not established; the paper also notes multiple possible mechanisms for fibrosis alleviation that were not fully distinguished.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures






Verification
Claims the paper makes
4 Valid · 0 Not valid · 21 Not checked · 85 Own results and interpretations
Every source the paper cites for this claim was checked and supports it.
In the paper
“Senescent cell elimination can indeed increase the proliferative capacity of stem cells and hence support tissue regeneration”
§ p21 maintains senescent cell viability under persistent DNA damage response by restraining JNK and caspase signaling > Discussion
What the sources say
- Supportedcites Chang et al, 2016 matched to “Clearance of senescent cells by ABT263 rejuvenates aged hematopoietic stem cells in mice” (2016) source
The Abstract (Results/Discussion passages) states that ABT263-mediated clearance of senescent cells 'significantly improved the clonogenicity (Fig. 3c) and long-term engraftment ability of irradiated HSCs' and that in normally aged mice it 'improved the clonogenicity of isolated MuSCs', with the authors concluding that 'selective clearance of SCs by a pharmacological agent is beneficial in part through its rejuvenation of aged tissue stem cells'. The passage on mechanism ('clearance of senescent HSCs by ABT263 treatment can promote the expansion of normal HSC clones') directly supports increased stem-cell proliferative capacity, and restored long-term repopulation/multilineage engraftment supports the regenerative consequence, in mice (HSCs and MuSCs). (LLM, conf=0.85)
- Supportedcites Yosef et al, 2016 matched to “Directed elimination of senescent cells by inhibition of BCL-W and BCL-XL” (2016) source
The Abstract states that 'Elimination of senescent cells from the epidermis leads to an increase in hair-follicle stem cell proliferation', and the Results (ABT-737 eliminates p53-induced senescent cells from skin) report increased Ki67+ and CD34+/CD49fhigh bulge stem cells that 'repopulate the stem cell compartment'. The Discussion extends this to regeneration: 'these findings suggest that the clearance of senescent cells can lead to tissue renewal and improved fitness', with relevance to other tissues (haematopoietic system, ref 42) noted. The claim's hedged modality ('can') matches the source; the only caveat is that the evidence is in mouse epidermis and the authors explicitly did not observe prominent hair regrowth within their time frame. (LLM, conf=0.82)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“These cells use autophagy for their maintenance”
§ p21 maintains senescent cell viability under persistent DNA damage response by restraining JNK and caspase signaling > Discussion
What the sources say
- Partly supportedcites Young et al, 2009 matched to “Autophagy mediates the mitotic senescence transition” (2009) sourceExperimental — accuracy not yet measured
Our copy confirms that senescent cells run elevated autophagy (Results, LC3-II accumulation and increased long-lived-protein degradation in Ras/MEK senescent IMR90, BJ and embryonic fibroblasts, with intact autophagic flux) and that autophagy is functionally required for the senescence phenotype, including IL6/IL8 production (Results and Discussion, Fig. 4D-E). But the source frames this as mediating the ACQUISITION/ESTABLISHMENT of senescence — 'important for the rapid protein remodelling required to make the efficient transition from a proliferative to a senescent state' (Introduction) — and it explicitly tested the maintenance idea and found against it: 'knockdown of ATG5/7 in established ras senescent BJ cells failed to reverse the senescence arrest... autophagy contributes to, at least, the establishment of senescence arrest' (Results and Discussion, Fig. 4). So the part attributed to this source that it does not support is 'for their maintenance' (ongoing maintenance of the established senescent state); the supported part is autophagy's role in establishing/quality of the senescence phenotype. (LLM, conf=0.72)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“DDR also participates in controlling regulation of the expression of immune ligands on senescent cells that mediate their recognition and consequent elimination by NK cells”
§ p21 maintains senescent cell viability under persistent DNA damage response by restraining JNK and caspase signaling > Discussion
What the sources say
- Supportedcites Sagiv et al, 2016 matched to “NKG2D ligands mediate immunosurveillance of senescent cells” (2016) source
The Introduction states that senescent cells present the NKG2D ligands MICA and ULBP2, enabling NK-cell recognition and elimination, and that a DNA damage response regulates ligand expression. The Discussion likewise attributes ligand regulation partly to the DNA damage response and says NKG2D receptor–ligand interaction is necessary for efficient elimination. (LLM, conf=0.94)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“Cellular stress induced by persistent DDR is a central mechanism that drives senescence in aging and age‐related diseases”
§ p21 maintains senescent cell viability under persistent DNA damage response by restraining JNK and caspase signaling > Discussion
What the sources say
- Supportedcites Campisi, 2013 matched to “Aging, Cellular Senescence, and Cancer” (2013) source
The 'Genomic Damage' subsection (CELLULAR SENESCENCE: CAUSES) states that senescence-efficacious lesions generate persistent DDR signaling, distinct from the transient DDR of mild damage, and 'Activation of Tumor Suppressors' states that persistent DDR signaling appears to initiate the senescence growth arrest, accompanied by stress-responsive p38MAPK/PKC signaling and increased ROS. The aging/age-disease linkage is carried by the Introduction (senescence links multiple aging pathologies, degenerative and hyperplastic) and by SENESCENT CELLS: CHARACTERISTICS, which reports persistent DNA damage foci in aging mouse and primate tissues, plus 'genomic damage—a common cause of cellular senescence' (Immune Clearance). The source hedges some of this ('may senesce primarily', 'appears to initiate') and notes DDR-independent routes (p38MAPK hyperactivation), but it does treat persistent DDR as the central initiating mechanism, matching the claim's scope. (LLM, conf=0.82)
- Not checked yetcites Munoz‐Espin & Serrano, 2014
- Not checked yetcites Ovadya & Krizhanovsky, 2014 matched to “Senescent cells: SASPected drivers of age-related pathologies” (2014) source
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Overall, the signal intensity of 1,595 unique genes changed significantly in response to p21 knockdown in DIS cells compared to only 82 in growing cells (Fig 2C).”
§ p21 maintains senescent cell viability under persistent DNA damage response by restraining JNK and caspase signaling > Results > Molecular pathways activated after p21 knockdown in DIS cells
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
63 more claims
Create a free account to see all 110 claims and to verify the 31 references still open.
- Probably not a substantial claim. 23
- It may state two separate claims as one. 24
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Senescence also is associated with upregulation of anti-apoptotic proteins of the BCL-2 family, particularly BCL-2, BCL-Xl, and BCL-W [14,15,143,144]”
From Mechanisms and Regulation of Cellular Senescence (2021) · cites this paper as [144]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“p21 upregulation has also been suggested as a mechanism that enables senescent cells to resist apoptosis, thereby facilitating their retention in tissues (Yosef et al, 2017).”
From Distinct senotypes in p16- and p21-positive cells across human and mouse aging tissues (2025) · cites this paper as Yosef et al, 2017
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“However, p16 might not be a specific or sensitive marker for cellular senescence since not all p16 highly expressing (p16high) cells are necessarily senescent [4] and some senescent cells do not express p16 [5,6].”
From The heterogeneity of cellular senescence: insights at the single-cell level (2023) · cites this paper as [5]
Experimental — accuracy not yet measuredIn the citing paper
“Upregulation of the cell cycle inhibitor p21 contributes to apoptosis resistance, for example, by inhibiting p53-mediated apoptosis after DNA damage [256,257] and by preventing the cleavage of the apoptosis effector caspase-3 and the activation of the JNK pathway (both required for apoptosis) [144].”
From Mechanisms and Regulation of Cellular Senescence (2021) · cites this paper as [144]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ p21 maintains senescent cell viability under persistent DNA damage response by restraining JNK and caspase signaling > Results > p21 knockout alleviates liver fibrosis
“JQuantification of Sirius Red staining presented in (H).”
§ p21 maintains senescent cell viability under persistent DNA damage response by restraining JNK and caspase signaling > Results > p21 knockout alleviates liver fibrosis
“ISirius Red staining of DIS cells after transduction with sip21 and siCtrl.”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ p21 maintains senescent cell viability under persistent DNA damage response by restraining JNK and caspase signaling > Results > p21 regulates the DNA damage response in senescent cells
“Each specimen was evaluated in triplicate. At least 50 cells were analyzed per replica”
§ p21 maintains senescent cell viability under persistent DNA damage response by restraining JNK and caspase signaling > Materials and Methods > Comet assay
“A minimum of 50 individual cells per sample were scored in duplicates.”
Citations
Cites
Exploration, normalization, and summaries of high density oligonucleotide array probe level data
Irizarry, R. A. (2003) · Biostatistics · doi:10.1093/biostatistics/4.2.249 · Cited by 10,603 · cited 1×
“Preprocessing was performed with the Robust Microarray Averaging algorithm (Irizarry et al , 2003).”
Cellular senescence: when bad things happen to good cells
Campisi, J., & d'Adda di Fagagna, F. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2233 · Cited by 4,441
Clearance of p16Ink4a-positive senescent cells delays ageing-associated disorders
Baker, D. J., Wijshake, T., Tchkonia, T., LeBrasseur, N. K., Childs, B. G., van de Sluis, B., Kirkland, J. L., & van Deursen, J. M. (2011) · Nature · doi:10.1038/nature10600 · Cited by 3,670 · cited 2×
“Elimination of senescent cells may therefore allow better recovery of tissues, consistent with the finding that senescent cell elimination via transgenic techniques improves aging-associated phenotypes (Baker et al , 2011, 2016).”
Aging, Cellular Senescence, and Cancer
Campisi, J. (2013) · Annual Review of Physiology · doi:10.1146/annurev-physiol-030212-183653 · Cited by 2,954 · cited 4×
“…secretory phenotype (SASP) (Coppe et al , 2008), which reinforces senescence arrest in an autocrine manner (Acosta et al , 2008, 2013; Kuilman et al , 2008; Wajapeyee et al , 2008) and mediates immune surveillance of the senescent cells (Sagiv & Krizhanovsky, 2013; Sagiv et al…”
InfluentialNaturally occurring p16Ink4a-positive cells shorten healthy lifespan
Baker, D. J., Childs, B. G., Durik, M., Wijers, M. E., Sieben, C. J., Zhong, J., A. Saltness, R., Jeganathan, K. B., Verzosa, G. C., Pezeshki, A., et al. (2016) · Nature · doi:10.1038/nature16932 · Cited by 2,876 · cited 2×
“Elimination of senescent cells may therefore allow better recovery of tissues, consistent with the finding that senescent cell elimination via transgenic techniques improves aging-associated phenotypes (Baker et al , 2011, 2016).”
Cellular senescence: from physiology to pathology
Muñoz-Espín, D., & Serrano, M. (2014) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3823 · Cited by 2,818 · cited 3×
“…in the organism promoting local inflammation that drives tissue aging, tissue destruction, and potentially also tumorigenesis and metastasis in a cell non-autonomous manner (Krtolica et al , 2001; Campisi, 2013; Munoz-Espin & Serrano, 2014; Ovadya & Krizhanovsky, 2014; Salama et al , 2014).”
p21 in cancer: Intricate networks and multiple activities
Abbas, T., & Dutta, A. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2657 · Cited by 2,712
Rb-mediated heterochromatin formation and silencing of E2F target genes during cellular senescence
Narita, M., Nuñez, S., Heard, E., Narita, M., Lin, A. W., Hearn, S. A., Spector, D. L., Hannon, G. J., & Lowe, S. W. (2003) · Cell · doi:10.1016/s0092-8674(03)00401-x · Cited by 2,278 · cited 1×
“…accompanied by the p53 (TP53) target p21 (CDKN1A), inhibits cyclin-dependent kinases (CDKs), thereby preventing phosphorylation of the retinoblastoma protein (pRb) and thus in turn suppressing the expression of proliferation-associated genes (Narita et al , 2003, 2006; Collado et al , 2007).”
A complex secretory program orchestrated by the inflammasome controls paracrine senescence
Acosta, J. C., Banito, A., Wuestefeld, T., Georgilis, A., Janich, P., Morton, J. P., Athineos, D., Kang, T.-W., Lasitschka, F., Andrulis, M., et al. (2013) · Nature Cell Biology · doi:10.1038/ncb2784 · Cited by 2,278 · cited 1×
“…termed the senescence-associated secretory phenotype (SASP) (Coppe et al , 2008), which reinforces senescence arrest in an autocrine manner (Acosta et al , 2008, 2013; Kuilman et al , 2008; Wajapeyee et al , 2008) and mediates immune surveillance of the senescent cells (Sagiv &…”
Oncogene-Induced Senescence Relayed by an Interleukin-Dependent Inflammatory Network
Kuilman, T., Michaloglou, C., Vredeveld, L. C. W., Douma, S., van Doorn, R., Desmet, C. J., Aarden, L. A., Mooi, W. J., & Peeper, D. S. (2008) · Cell · doi:10.1016/j.cell.2008.03.039 · Cited by 2,086
Cited by
Items 101–200 of 339
Rising from the ashes: cellular senescence in regeneration
Walters, H., & Yun, M. H. (2020) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2020.06.002 · Cited by 32
The p-rpS6-zone delineates wounding responses and the healing process
Ring, N. A. R., Dworak, H., Bachmann, B., Schädl, B., Valdivieso, K., Rozmaric, T., Heimel, P., Fischer, I., Klinaki, E., Gutasi, A., et al. (2023) · Developmental Cell · doi:10.1016/j.devcel.2023.04.001 · Cited by 31
Understanding cellular senescence: pathways involved, therapeutics and longevity aiding
Kumar, A., & Thirumurugan, K. (2023) · Cell Cycle · doi:10.1080/15384101.2023.2287929 · Cited by 31
“P38-MAPK and ERK1/2 help in the expression of effector p21 which restricts cell death in senescent cells [91].”
BackgroundFrom the divergence of senescent cell fates to mechanisms and selectivity of senolytic drugs
L’Hôte, V., Mann, C., & Thuret, J. (2022) · Open Biology · doi:10.1098/rsob.220171 · Cited by 31
“In addition to its functions as a cell–cycle inhibitor, p21 also has anti-apoptotic activity in senescent cells [85].”
BackgroundSriratanasak, N., Chunhacha, P., Zin, Z., & Chanvorachote, P. (2022) · Biomedicines · doi:10.3390/biomedicines10112703 · Cited by 31
Increased double strand breaks in diabetic β-cells with a p21 response that limits apoptosis
Tay, V. S. Y., Devaraj, S., Koh, T., Ke, G., Crasta, K., & Ali, Y. (2019) · Scientific Reports · doi:10.1038/s41598-019-54554-8 · Cited by 31
Single-cell and spatial detection of senescent cells using DeepScence
Qu, Y., Ji, B., Dong, R., Gu, L., Chan, C., Xie, J., Glass, C., Wang, X.-F., Nixon, A. B., & Ji, Z. (2025) · Cell Genomics · doi:10.1016/j.xgen.2025.101035 · Cited by 30
Molecular and immunological developments in placentas
Nakashima, A., Shima, T., Aoki, A., Kawaguchi, M., Yasuda, I., Tsuda, S., Yoneda, S., Yamaki‐Ushijima, A., Cheng, S., Sharma, S., et al. (2021) · Human Immunology · doi:10.1016/j.humimm.2021.01.012 · Cited by 30
Yu, J.-B., Lee, D., Padanilam, B. J., & Kim, J. (2022) · Cells · doi:10.3390/cells11213472 · Cited by 29
Beach, T. A., Groves, A. M., Johnston, C. J., Williams, J. P., & Finkelstein, J. N. (2018) · International Journal of Radiation Biology · doi:10.1080/09553002.2018.1516907 · Cited by 29
“…p21, the main function of which is to maintain genomic stability by contributing to cell cycle arrest, in particular its permanent form of cellular senescence (Campisi and d’Adda di Fagagna 2007), a process that regulates tissue integrity following injury and during remodeling (Yosef et al. 2017).”
InfluentialDistinct secretomes in p16- and p21- positive senescent cells across tissues
Saul, D., Jurk, D., Doolittle, M. L., Kosinsky, R. L., Monroe, D. G., LeBrasseur, N. K., Robbins, P. D., Niedernhofer, L. J., Khosla, S., & Passos, J. F. (2023) · doi:10.1101/2023.12.05.569858 · Cited by 28
“…a recent study has demonstrated that p21 and p16 overexpression elicit distinct SASPs, with p21's SASP promoting immunosurveillance 18 . p21 upregulation has also been suggested as a mechanism that enables senescent cells to resist apoptosis thereby facilitating their retention in tissues 34 .”
BackgroundPapismadov, N., Gal, H., & Krizhanovsky, V. (2017) · Cell Cycle · doi:10.1080/15384101.2017.1377500 · Cited by 28
“Surprisingly, increased levels of p21, which promote cell cycle arrest in senescent cells, also maintain their viability, especially when senescence is driven by DNA-damage.6 Indeed, persistent DNA damage response (DDR) is a central molecular mechanism that mediates senescence in aging and age-related diseases and ind…”
BackgroundSelf-citationThe interaction between cellular senescence and chronic kidney disease as a therapeutic opportunity
Zhao, J.-L., Qiao, X.-H., Mao, J., Liu, F., & Fu, H. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.974361 · Cited by 27
“The activation of p21 prevents senescent cells from apoptosis by limiting JNK signaling and caspase (Yosef et al., 2017).”
BackgroundGao, Y., Yang, X. Y., Wang, J., Liu, H., & Zheng, N. (2022) · Toxins · doi:10.3390/toxins14060368 · Cited by 26
Johnson, A. C. M., & Zager, R. A. (2018) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfy029 · Cited by 26
Navigating the complex role of senescence in liver disease
Li, Q.-J., & Wang, L. (2024) · Chinese Medical Journal · doi:10.1097/cm9.0000000000003439 · Cited by 25
Gromadzka, G., Tarnacka, B., & Cieślik, M. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27010522 · Cited by 24
Miyahara, S., Ohuchi, M., Nomura, M., Hashimoto, E., Soga, T., Saito, R., Hayashi, K., Sato, T., Saito, M., Yamashita, Y., et al. (2024) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2024.107678 · Cited by 25
“Given that p53 loss of function reportedly promotes relatively severe DNA damage (33), we evaluated activation status of proteins functioning in the DDR in both TP53 WT and TP53 KO FDX2-iKO JHOC5 cells.”
Xu, M., Li, Z., Yang, L., Zhai, W., Wei, N., Zhang, Q., Chao, B., Huang, S., & Cui, H. (2020) · BioMed Research International · doi:10.1155/2020/5848497 · Cited by 24
Unraveling the effect of intra- and intercellular processes on acetaminophen-induced liver injury
Heldring, M. M., Shaw, A. H., & Beltman, J. B. (2022) · npj Systems Biology and Applications · doi:10.1038/s41540-022-00238-5 · Cited by 23
Saleh, T., Khasawneh, A. I., Himsawi, N. M., Abu-Raideh, J. A., Ejeilat, V., Elshazly, A. M., & Gewirtz, D. A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232415512 · Cited by 24
Stress Hormones: Unveiling the Role in Accelerated Cellular Senescence
Qin, T., Chen, T., Ma, R., Li, H., Li, C., Zhao, J., Yuan, J., Zhang, Z., & Ning, X. (2024) · Aging and Disease · doi:10.14336/ad.2024.0262 · Cited by 23
MBNL2 Regulates DNA Damage Response via Stabilizing p21
Cai, J. L., Wang, N., Lin, G., Zhang, H., Xie, W., Zhang, Y., & Xu, N. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22020783 · Cited by 23
The intricate nature of senescence in development and cell plasticity
Gal, H., Majewska, J., & Krizhanovsky, V. (2021) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2021.01.004 · Cited by 22
Self-citationCellular Senescence and Aging in Myotonic Dystrophy
Hasuike, Y., Mochizuki, H., & Nakamori, M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23042339 · Cited by 22
Artemisia argyi exhibits anti-aging effects through decreasing the senescence in aging stem cells
Ho, T., Goswami, D., Kuo, W., Kuo, C., Yen, S. C., Lin, P., Lin, S., Hsieh, D. J., Shibu, M. A., & Huang, C. (2022) · Aging · doi:10.18632/aging.204210 · Cited by 22
Hussain, F., Basu, S., Heng, J. J. H., Loo, L., & Zink, D. (2020) · Archives of Toxicology · doi:10.1007/s00204-020-02778-3 · Cited by 22
CopA3 peptide induces permanent cell-cycle arrest in colorectal cancer cells
Dey, D. K., & Kang, S. C. (2021) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2021.111497 · Cited by 22
Banerjee, P., Gaddam, N., Pandita, T. K., & Chakraborty, S. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24032877 · Cited by 21
“The p21cip1 is one of the founding members of the mammalian CDK inhibitor family and, upon activation, p21cip1 binds with many apoptotic genes, including caspases; as a result, it inhibits apoptosis and induces senescence [74].”
BackgroundMalhotra, L., Goyal, H., Jhuria, S., Dev, K., Kumar, S., Kumar, M., Kaur, P., & Ethayathulla, A. S. (2020) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2020.129807 · Cited by 21
Kim, J., Ahn, D., & Park, C. (2021) · Journal of Molecular Biology · doi:10.1016/j.jmb.2021.166808 · Cited by 21
Creatine and Nicotinamide Prevent Oxidant-Induced Senescence in Human Fibroblasts
Mahajan, A. S., Arikatla, V. S., Thyagarajan‐Sahu, A., Zhelay, T., Sahu, R. P., Kemp, M. G., Spandau, D. F., & Travers, J. B. (2021) · Nutrients · doi:10.3390/nu13114102 · Cited by 21
Targeting cellular senescence to combat cancer and ageing
Wang, C., Hao, X., & Zhang, R. (2022) · Molecular Oncology · doi:10.1002/1878-0261.13266 · Cited by 21
Naismith, E., Pangrazzi, L., Grasse, M., Keller, M., Miggitsch, C., Weinberger, B., Trieb, K., & Grubeck‐Loebenstein, B. (2019) · Immunity & Ageing · doi:10.1186/s12979-019-0161-z · Cited by 20
Carbofuran accelerates the cellular senescence and declines the life span of spns1 mutant zebrafish
Khan, A., Fahad, T. M., Akther, T., Zaman, T., Hasan, M. F., Khan, M. R. I., Islam, M. S., & Kishi, S. (2020) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.16171 · Cited by 20
Sobeai, H. M. A., Alohaydib, M. H., Alhoshani, A., Alhazzani, K., Almutairi, M. M., Saleh, T., Gewirtz, D. A., & Alotiabi, M. R. (2021) · Saudi Pharmaceutical Journal · doi:10.1016/j.jsps.2021.12.004 · Cited by 20
Cellular senescence, p21, and the path to fibrosis
Turano, P. S., & Herbig, U. (2024) · The EMBO Journal · doi:10.1038/s44318-024-00245-8 · Cited by 20
“…the production ECM components by senescent as well as by non-senescent cells, while also causing rapid cell death of p21-expressing senescent cells (Yosef et al, 2017), it is currently unclear whether the therapeutic effects of targeting p21 is primarily due to the elimination of senescent cells…”
Multifaceted roles of Meg3 in cellular senescence and atherosclerosis
Cheng, X., Ali, M. S. S. H., Baki, V. B., Moran, M., Su, H., & Sun, X. (2024) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2024.117506 · Cited by 19
“Cyclin-dependent kinase inhibitors p21 and p16 are markers of cellular senescence [35-38].”
Radiation Promotes Acute and Chronic Damage to Adipose Tissue
Liermann-Wooldrik, K. T., Kosmacek, E. A., McDowell, J. A., Takkar, S., Murthy, D., Singh, P. K., Schott, M. B., Ponnusamy, M. P., & Oberley‐Deegan, R. E. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26125626 · Cited by 19
“Cellular senescence is believed to help maintain tissue integrity upon DNA damage, such as after radiation exposure [29–31].”
Norton, E. S., Whaley, L. A., Jones, V. K., Brooks, M., Russo, M. N., Morderer, D., Jessen, E., Schiapparelli, P. V., Ramos‐Fresnedo, A., Zarco, N., et al. (2024) · Science Advances · doi:10.1126/sciadv.adn1607 · Cited by 18
“We therefore decided to investigate alterations in senescence using the markers p21 and p16, important regulators of the DNA damage response in senescent cells ( 39 , 40 ).”
Strzeszewska, A., Staniak, K., Czarnecka‐Herok, J., Rafiee, M., Herok, M., Mosieniak, G., Krijgsveld, J., & Sikora, E. (2021) · Cancers · doi:10.3390/cancers13092115 · Cited by 18
Yang, Y., Mihajlovic, M., Valentijn, F. A., Nguyen, T. Q., Goldschmeding, R., & Masereeuw, R. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.791612 · Cited by 18
The Uremic Toxin Indoxyl Sulfate Accelerates Senescence in Kidney Proximal Tubule Cells
Yang, Y., Mihajlovic, M., Janssen, M. J., & Masereeuw, R. (2023) · Toxins · doi:10.3390/toxins15040242 · Cited by 20
“Here, our findings suggest that IS accelerates or maintains the expression of p21 at a high level [46], which results in a permanent cell cycle arrest and leads to chronic senescence.”
BackgroundZhao, Y., Tang, X., Huang, Y., Tang, Q., Ma, C., Zheng, F., Wu, W., & Hann, S. S. (2019) · OncoTargets and Therapy · doi:10.2147/ott.s226830 · Cited by 18
“28 Thus, the controversial roles of the two-faced involvement of p21 in cancer development and a therapeutic target might exist.”
DNA methylation protects cancer cells against senescence
Chen, X., Yamaguchi, K., Rodgers, B., Goehrig, D., Vindrieux, D., Lahaye, X., Nolot, M., Ferry, L., Lanciano, S., Martin, N., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-61157-7 · Cited by 17
“…increased apoptosis in these cells. p21 has diverse functions depending on its cellular localization 51 : nuclear p21 inhibits various Cyclin/CDK complexes and restricts cell cycle progression, whereas cytoplasmic p21 has pro-survival effects by restraining JNK signaling and caspase activity 52 .”
Erratum To: Molecular pathways of senescence regulate placental structure and function
Gal, H., Lysenko, M., Stroganov, S., Vadai, E., Youssef, S. A., Geffen, K. T., Rotkopf, R., Biron‐Shental, T., de Bruin, A., Neeman, M., et al. (2020) · The EMBO Journal · doi:10.15252/embj.2020105972 · Cited by 17
Self-citationDNA methylation protects cancer cells against senescence
Chen, X., Yamaguchi, K., Rodgers, B., Goehrig, D., Vindrieux, D., Lahaye, X., Nolot, M., Ferry, L., Martin, N., Dubus, P., et al. (2024) · doi:10.1101/2024.08.23.609297 · Cited by 17
Fernandes, S. E., & Saini, D. K. (2021) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2021.744013 · Cited by 16
“For instance, it has been demonstrated that p21 in DNA damageinduced senescent cells promotes cell viability by modulating the activation of JNK and pro-caspases, providing evidence of crosstalk between DNA damage signalling and pro-survival pathways (Yosef et al., 2017).”
BackgroundFionda, C., Bona, D. D., Kosta, A., Stabile, H., Santoni, A., & Cippitelli, M. (2019) · Cancers · doi:10.3390/cancers11060810 · Cited by 16
“This protein blocks cell cycle progression, resulting in a temporary or permanent cell cycle arrest (senescence), and inhibits apoptosis [9,10].”
Backgroundp21 facilitates chronic lung inflammation via epithelial and endothelial cells
Levi, N., Papismadov, N., Majewska, J., Roitman, L., Wigoda, N., Eilam, R., Tsoory, M., Rotkopf, R., Ovadya, Y., Akiva, H., et al. (2023) · Aging · doi:10.18632/aging.204622 · Cited by 15
“Furthermore, p21 silencing results in elimination of senescent cells via apoptosis [60].”
InfluentialSelf-citationRole of tumor cell senescence in non-professional phagocytosis and cell-in-cell structure formation
Gottwald, D., Putz, F., Hohmann, N., Büttner-Herold, M. J., Hecht, M., Fietkau, R., & Distel, L. V. (2020) · BMC Molecular and Cell Biology · doi:10.1186/s12860-020-00326-6 · Cited by 15
Chronic liver diseases: From development to novel pharmacological therapies: IUPHAR Review 37
Borrello, M. T., & Mann, D. A. (2022) · British Journal of Pharmacology · doi:10.1111/bph.15853 · Cited by 15
“This association between hepatocellular senescence and fibrosis has also been noted in experimental models either where telomerase is deleted, which accelerates fibrosis, or when the p21 cell cycle arrest gene is deleted which protects from fibrosis (Rudolph et al., 2000; Yosef et al., 2017).”
BackgroundConover, C. A., & Bale, L. K. (2022) · Experimental Gerontology · doi:10.1016/j.exger.2022.112070 · Cited by 15
The Impact of Zinc on Manganese Bioavailability and Cytotoxicity in HepG2 Cells
Michaelis, V., Kasper, S., Naperkowski, L., Pusse, J., Thiel, A., Ebert, F., Aschner, M., Schwerdtle, T., Haase, H., & Bornhorst, J. (2023) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.202200283 · Cited by 15
Cellular Senescence in Liver Cancer: How Dying Cells Become “Zombie” Enemies
Gazzillo, A., Volponi, C., Soldani, C., Polidoro, M. A., Franceschini, B., Lleò, A., Bonavita, E., & Donadon, M. (2023) · Biomedicines · doi:10.3390/biomedicines12010026 · Cited by 15
Exploring the role and mechanisms of MAGEA4 in tumorigenesis, regulation, and immunotherapy
Zhu, W., Yi, Q., Chen, Z., Wang, J., Zhong, K., Ouyang, X., Yang, K., Jiang, B., Zhong, J., & Zhong, J. (2025) · Molecular Medicine · doi:10.1186/s10020-025-01079-8 · Cited by 14
Low-dose tributyltin triggers human chondrocyte senescence and mouse articular cartilage aging
Chung, Y.-P., Weng, T., Chan, D., Yang, R., & Liu, S. (2022) · Archives of Toxicology · doi:10.1007/s00204-022-03407-x · Cited by 14
“Although both ERK1/2 and p38 MAPKs have been suggested to be most closely linked to cell senescence, studies have revealed that JNK MAPK can also be involved in senescent traits (Anerillas et al. 2020; Kanatsu-Shinohara et al. 2019; Lee et al. 2010; Yosef et al. 2017).”
BackgroundChen, L., Zhang, L., Jin, G., Liu, Y., Guo, N., Sun, H., Jiang, Y., Zhang, X., He, G., Lv, G., et al. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.112984 · Cited by 14
Reduced proliferation capacity of lung cells in chronic obstructive pulmonary disease
Bartling, B., & Hofmann, H. (2018) · Zeitschrift für Gerontologie und Geriatrie · doi:10.1007/s00391-018-1377-9 · Cited by 14
“For how long senescent cells can still maintain their viability depends on the function of the cell cycle inhibitory protein p21Cip1 [25].”
BackgroundMukherjee, S., & Ray, S. K. (2022) · Current Molecular Medicine · doi:10.2174/1566524022666220111122450 · Cited by 14
An in vitro senescence model of gingival epithelial cell induced by hydrogen peroxide treatment
Giri, S., Takada, A., Paudel, D., Yoshida, K., Furukawa, M., Kuramitsu, Y., Matsushita, K., Abiko, Y., & Furuichi, Y. (2021) · Odontology · doi:10.1007/s10266-021-00630-3 · Cited by 14
Mury, P., Cagnone, G., Dagher, O., Wünnemann, F., Voghel, G., Beaudoin, M., Lambert, M., Miquel, G., Noly, P., Perrault, L. P., et al. (2024) · JACC Basic to Translational Science · doi:10.1016/j.jacbts.2024.06.012 · Cited by 13
de Celis, M. F. R., & Bonner‐Weir, S. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1217729 · Cited by 13
Alsalem, M., Ellaithy, A., Bloukh, S., Haddad, M., & Saleh, T. (2024) · Supportive Care in Cancer · doi:10.1007/s00520-023-08287-0 · Cited by 13
“TIS was also precipitated in normal human lung fibroblasts (IMR-90), mouse embryonic fibroblasts (MEFs), and in normal human skin fibroblasts (BJ cells) due to the exposure to the chemotherapeutic, etoposide [102].”
Dalmao‐Fernández, A., Hermida‐Gómez, T., Nogueira-Recalde, U., Rego‐Pérez, I., Blanco, F. J., & Fernández-Moreno, M. (2024) · Cells · doi:10.3390/cells13110976 · Cited by 13
Juran, C. M., Žvirblytė, J., Cheng-Campbell, M., Blaber, E. A., & Almeida, E. A. C. (2021) · Stem Cell Research · doi:10.1016/j.scr.2021.102513 · Cited by 13
Molecular Targeting of the Most Functionally Complex Gene in Precision Oncology: p53
Brown, D. W., Beatty, P. H., & Lewis, J. D. (2022) · Cancers · doi:10.3390/cancers14215176 · Cited by 13
Pham, A. M., Ortiz, L. E., Lukacher, A. E., & Kwun, H. J. (2023) · Cells · doi:10.3390/cells12030380 · Cited by 13
“This p21 knockdownmediated cell death may be caused by the re-entry of senescent cells back into the cell cycle, which enhances the activation of DDR as shown by others [63].”
BackgroundDemeule, M., Currie, J.-C., Charfi, C., Zgheib, A., Cousineau, I., Lullier, V., Béliveau, R., Marsolais, C., & Annabi, B. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1355945 · Cited by 12
da Silva, C. M., Caetano, F. H., Pereira, F. D. C., Marin‐Morales, M. A., Sakane, K. K., & Moraes, K. C. M. (2019) · BMC Complementary and Alternative Medicine · doi:10.1186/s12906-019-2591-8 · Cited by 12
AMPK/Sirt1-mediated inflammation is positively correlated with myocardial fibrosis during ageing
Song, Y., Zhang, Y., Zhang, X., Hu, S., Wang, J., Deng, G., & Zhou, Z. (2022) · Acta cardiologica. Supplementum · doi:10.1080/00015385.2022.2119667 · Cited by 12
“Furthermore, NF-jB activity is significantly increased in senescent cells, such as in haematopoietic stem and progenitor cells [19], and were proved to induce TNF-a secretion and JNK activation to regulate the death of senescent cells [20].”
BackgroundLemay, S.-E. S., Mougin, M., Sauvaget, M., Kabbout, R. E., Valasarajan, C., Yamamoto, K., Martineau, S., Pelletier, A., Bilodeau, C., Grobs, Y., et al. (2025) · Cell Reports Medicine · doi:10.1016/j.xcrm.2025.101964 · Cited by 11
“…both in vitro (Figures 3 and 4) and in vivo (Figures 5 and S8) and that persistent expression of p21 was reported to maintain the viability of senescent cells, 41 we first examined whether the sequential targeting of AURKB/p21 axis promotes the elimination of senescent PAH-PASMCs in vitro .”
Aging and lung diseases: Unraveling mechanisms and therapeutic targets
Zhou, Y., Chen, G., Li, X., Li, X., Lin, Z., Liu, L., Pu, D., Chen, J., Chen, Y., Lin, Z., et al. (2025) · Chinese Medical Journal - Pulmonary and Critical Care Medicine · doi:10.1016/j.pccm.2025.11.005 · Cited by 11
“42 The pRb/p16 pathway also regulates senescence and promotes self-renewal and differentiation of AEC2s.”
Lu, W., Ren, S., Dong, W., Li, X., Zheng, Z., Jia, Y., & Xue, Y. (2022) · Acta Biochimica et Biophysica Sinica · doi:10.3724/abbs.2022055 · Cited by 11
“It was reported that p21deficient mice could avoid liver fibrosis because of the elimination of senescent liver stellate cells [53].”
BackgroundSaleh, T., Naffa, R. G., Barakat, N. A., Ismail, M. A., Alotaibi, M. R., & Alsalem, M. (2024) · Neurotoxicity Research · doi:10.1007/s12640-024-00690-7 · Cited by 11
“TIS is also frequently seen as the primary response to etoposide in normal human lung fibroblasts (IMR-90), mouse embryonic fibroblasts (MEFs), and in normal human skin fibroblasts (BJ cells) (Yosef et al. 2017).”
Systematic transcriptomic analysis and temporal modelling of human fibroblast senescence
Scanlan, R.-L., Pease, L., O’Keefe, H., Guimera, A. M., Rasmussen, L. J., Wordsworth, J., & Shanley, D. P. (2024) · Frontiers in Aging · doi:10.3389/fragi.2024.1448543 · Cited by 11
Zhuo, J., Chu, L., Liu, D., Zhang, J., Chen, W., Huang, H., Yu, Q., Meng, X., Zou, F., Cai, S., et al. (2024) · Phytotherapy Research · doi:10.1002/ptr.8374 · Cited by 11
“Accumulating evidence has indicated that P21 and P16 serve as critical molecular markers of cellular aging and that P21 is commonly observed to accumulate in the development phase of senescence (Fragkos, Jurvansuu, and Beard 2009; Yosef et al. 2017).”
Gala, D., & Fábián, Z. (2021) · Stem Cells International · doi:10.1155/2021/8899756 · Cited by 11
Gao, Y., Li, L., Yan, J., Hou, X., Jia, Y., Chang, Z., Guan, X., & Qin, Y. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2020.627845 · Cited by 11
Wu, J., Zhang, L., Zhao, Z., Liu, Y., Li, Z., Feng, X., Zhang, L., Yao, X., Du, J., Chen, L., et al. (2025) · Ageing Research Reviews · doi:10.1016/j.arr.2025.102783 · Cited by 10
Xie, F., Xi, C., Bao, G., Yang, B., Zheng, X., Fu, B., & Zheng, Z. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1712974 · Cited by 10
Therapy-Induced Tumor Cell Senescence: Mechanisms and Circumvention
Zamkova, M. A., Александровна, П. Н., Tatarskiy, V. V., & Shtil, A. A. (2023) · Biochemistry (Moscow) · doi:10.1134/s000629792301008x · Cited by 10
“For example, knockdown or knockout of p21 and following exposure to chemotherapeutics resulted in apoptosis, but not in senescence [47, 76, 77].”
BackgroundWattanapitayakul, S. K., Jarisarapurin, W., Kunchana, K., Setthawong, V., & Chularojmontri, L. (2023) · Preventive Nutrition and Food Science · doi:10.3746/pnf.2023.28.3.235 · Cited by 10
“NF-B activation, observed in senescent fibroblasts, triggers TNF- secretion and JNK activation (Yosef et al., 2017).”
BackgroundRinaldi, M., Pezone, A., Quadrini, G. I., Abbadessa, G., Laezza, M. P., Passaro, M. L., Porcellini, A., & Costagliola, C. (2024) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2024.1371745 · Cited by 11
“Surprisingly, this anti-proliferative response (induction of p16 and p21) is also present in non-replicating postmitotic cells and stem cells following DNA damage to maintain cell survival (Yosef et al., 2017; Kumari and Jat, 2021; Von Zglinicki et al., 2021).”
BackgroundNeuwahl, J., Neumann, C. A., Fitz, A. C., Biermann, A. D., Magel, M., Friedrich, A., Sellin, L. K., Stork, B., Piekorz, R. P., Proksch, P., et al. (2024) · Cell Death and Disease · doi:10.1038/s41419-024-06755-x · Cited by 10
“This conclusion is in agreement with other reports demonstrating that the persistent expression of p21 is required for the survival of senescent cells [19, 29, 30].”
BackgroundResultYousef, A., Fang, L., Heidari, M., Kranrod, J. W., & Seubert, J. M. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1486717 · Cited by 10
Rassamegevanon, T., Feindt, L., Koi, L., Müller, J., Freudenberg, R., Löck, S., Sihver, W., Çevik, E., Kühn, A. C., von Neubeck, C., et al. (2021) · Cancers · doi:10.3390/cancers13225595 · Cited by 10
Seshadri, V., Chng, C., Tyler, J., Adikerta, C., Baghaei, K., Wang, Y., Gueven, N., Ricardo, S. D., & Azimi, I. (2025) · Aging Cell · doi:10.1111/acel.70209 · Cited by 9
“Higher levels of p21 render cells more resistant to apoptosis, as senescent cells are known to exhibit anti-apoptotic properties (Yosef et al. 2017).”
Network-informed discovery of multidrug combinations for ERα+/HER2-/PI3Kα-mutant breast cancer
Hany, D., Zoetemelk, M., Bhattacharya, K., Nowak-Sliwinska, P. M., & Picard, D. (2023) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-023-04730-x · Cited by 9
“p21 has been shown to be induced upon DNA damage and to maintain the viability of senescent cells [103].”
BackgroundHe, M. T., Nguyen, Q. N., Cho, E. J., Kim, S. H., Park, S., Park, J. Y., Lee, S., & Kang, K. S. (2023) · Journal of Dietary Supplements · doi:10.1080/19390211.2023.2284985 · Cited by 9
“It has been found that senescent cells lead a persistent DNA damage (Yosef et al. 2017).”
BackgroundWu, Q., Zheng, Q., Yuan, L., Gao, D., Hu, Y., Jiang, X., Zhai, Q., Liu, M., Xu, L., Xu, H., et al. (2024) · Cell Cycle · doi:10.1080/15384101.2024.2342714 · Cited by 9
“On the other hand, p21 assumes a crucial role in sustaining the viability of senescent cells amid prolonged DNA damage response by suppressing JNK and caspase signaling [50].”
BackgroundHaghi‐Aminjan, H., Baeeri, M., Khalid, M., Rahimifard, M., Mahdizadeh, E., Shayesteh, M. R. H., & Abdollahi, M. R. (2021) · Journal of Cluster Science · doi:10.1007/s10876-021-02152-y · Cited by 9
Muscle Stem Cell Function Is Impaired in β2-Adrenoceptor Knockout Mice
Koike, T. E., Fuziwara, C. S., Brum, P. C., Kimura, E. T., Rando, T. A., & Miyabara, E. H. (2022) · Stem Cell Reviews and Reports · doi:10.1007/s12015-022-10334-y · Cited by 9
“We also evaluated the mRNA levels of Cdkn1a in differentiating myoblasts (grown in DM for 24 h).”
BackgroundInfluentialZnhit1 Regulates p21 Cip1 to Control Mouse Lens Differentiation
Lü, J., An, J., Wang, J., Cao, X., Cao, Y., Huang, C., Jiao, S., Yan, D., Lin, X., & Zhou, X. (2022) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.63.4.18 · Cited by 9
“Upregulated p21 Cip1 expression is a main driver of cell cycle arrest and tissue fibrosis, 62,63 as well as p27 Kip1 .”
Glyphosate Causes Vascular Toxicity through Cellular Senescence and Lipid Accumulation
Lu, J., Zhang, C., Wang, W., Xu, W., Chen, W., Tao, L., Li, Z., Zhang, Y., & Cheng, J. (2023) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.3c00116 · Cited by 9
Song, J., Lee, D., Hwang, B., Kim, S., Kim, J., Park, S., Choo, S., Hwang, S.-K., Kim, H., Yun, S. J., et al. (2025) · Scientific Reports · doi:10.1038/s41598-025-11700-9 · Cited by 8
“Supporting this notion, p21WAF1 loss in senescent cells triggered activation of the JNK–ATM–NF-κB axis and promoted apoptosis 54 .”
Parekh, M., Adhikari, Y., Deshpande, N. R., Wong, R., Price, M. O., Price, F. W., & Jurkunas, U. V. (2026) · Cell Death and Disease · doi:10.1038/s41419-026-08425-6 · Cited by 8
Cell Senescence and the Genetics of Melanoma Development
Constantinou, S. M., & Bennett, D. C. (2024) · Genes Chromosomes and Cancer · doi:10.1002/gcc.23273 · Cited by 8
“Among p53 effectors, the cyclin-dependent kinase inhibitor p21 ( CDKN1A ) is vital in mediating cell senescence in relevant cell types [20, 80] (Figure 1), and also promotes cell viability by inhibiting pro-apoptotic effectors [81].”
Identification and validation of biomarkers related to ferroptosis in idiopathic pulmonary fibrosis
Yue, M., Luan, R., Ding, D., Wang, Y., Xue, Q., & Yang, J. (2025) · Scientific Reports · doi:10.1038/s41598-025-93217-9 · Cited by 8
“This process promotes the production of extracellular matrix (ECM) and cellular senescence, thus driving the progression of fibrosis 47,48 .”
Sexual dimorphism in liver cell cycle and senescence signalling pathways in young and old rats
Lomas‐Soria, C., Cox, L. A., Nathanielsz, P. W., & Zambrano, E. (2021) · The Journal of Physiology · doi:10.1113/jp281822 · Cited by 8
“Senescent cells increase their content of cell cycle arrest proteins, such as the inhibitor of the cell cycle p21 (Yosef et al. 2017).”
Background
Metadata
- Authors
- Yosef, R., Pilpel, N., Papismadov, N., Gal, H., Ovadya, Y., Vadai, E., Miller, S., Porat, Z., Ben‐Dor, S., & Krizhanovsky, V.
- Affiliations
- Weizmann Institute of Science (IL)
- Corresponding author
- Krizhanovsky, Valery
- Venue
- The EMBO Journal
- Published
- 2017-06-12
- Volume
- 36
- Issue
- 15
- Pages
- 2280-2295
- ISSN
- 0261-4189 (ISSN-L)
- 1460-2075
- PMC
- PMC5538795
- OpenAlex
- W2624008928
- Cited by
- 293
- References
- 58
- Citations by year
- 2026: 24 · 2025: 38 · 2024: 39 · 2023: 41 · 2022: 36 · 2021: 50 · 2020: 27 · 2019: 26 · 2018: 11 · 2017: 1
- FWCI
- 13.15
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor)
- Locations
- The EMBO Journal (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- European Research Council (309688)
- Israel Science Foundation (634/15)
- Bruce Kanter Fund
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Keywords
- cellular senescence, p21, DNA damage response, ATM, NF-κB signaling, JNK signaling, caspase signaling, TNF-α, liver stellate cells, liver fibrosis, collagen synthesis, aging
- MeSH terms
- Animals, Cell Line, Cell Survival, DNA Damage, Gene Expression Regulation, Humans, Caspases, MAP Kinase Signaling System, Cyclin-Dependent Kinase Inhibitor p21, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-05, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-05 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (qwen3.8-omni-flash and gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.